Company Lookup

Market News

This Month News

This Month News

send to a friend by email

JPH posts net income of $0.30 million in Q1 2024


According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the 1st Quarter of 2024, Net profit after tax of the period reached 302,217 USD Compared with Net profit after tax 1,501,916 USD for 2023, a net decrease in profit of 79.88%.Total assets of the company reached 84,095,278 USD compared with total assets of 86,320,946 USD at the end of year 2023, a net decrease of 2.58%.Total liabilities of the company reached 16,612,214 USD compared with total liabilities of 17,442,878 USD at the end of year 2023, a net decrease of 4.76%. Net ownership equity of the company reached 67,483,064 USD (Including Non-Controlling Interests of 1,056,633 USD) compared with total owner equity of 68,878,068 USD (Including Non-Controlling Interests of 1,037,498 USD) at the end of year 2023, a net decrease of 2.03%.



Al-Quds Index continued to decline amid lack of general incentives

The PEX records average PE of 19.7x and average P/BV of 1.10x in Q1 2024

JCC approves distributing 10% cash dividends for the year 2023



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013
PHP Notice: Undefined index: archive in C:\Inetpub\wwwroot\sahem\menu.php on line 403